InvestSMART

Artrya Limited (ASX:AYA)

ALERT: Price-sensitive ASX Announcement for AYA
Current share price for AYA : $5.640 3.46 (158.72%)+
Announcement
Release
9 Sep 2025 9:20AM
Price at Release
$2.180
Full Release
download
Summary
Artrya Limited announced a successful A$75 million two-tranche placement and the launch of up to A$5 million share purchase plan (SPP) to support the accelerated commercialization and expansion of its Salix® software platform in the U.S. market. The placement price was A$2.05 per share, with the funds allocated for U.S. commercial expansion, customer support, and product development. The Salix® platform recently received FDA clearance for its Coronary Plaque module. The placement was managed by Petra Capital, and the SPP is available to eligible shareholders on the record date of 8 September 2025. The timetable includes various key dates for settlement and allotment.
Key Points
  • Successful A$75 million two-tranche placement at A$2.05 per share.
  • Launch of up to A$5 million share purchase plan (SPP).
  • Funds to support U.S. commercialization and expansion of Salix® software.
  • FDA clearance received for Salix® Coronary Plaque module.
  • SPP available to eligible shareholders with a record date of 8 September 2025.
  • Placement managed by Petra Capital.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.